Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Octagon Capital Advisors LP
Form 13F · Q2 2026

Octagon Capital Advisors LP

CIK 1839435申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$11.1亿
申报组合市值
27
持仓数量
12
Quarters on record
Top 50
持仓数量

Octagon Capital Advisors LP——持仓

共 27 个持仓中的前 26 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1DNTH Dianthus Therapeutics Inc1.8M−5.4%$1.8亿16.1%
2DFTX Definium Therapeutics Inc3.0M+20.9%$1.4亿12.5%
3ABVX Abivax Sa993,000+46.7%$1.3亿11.9%
4COGT Cogent Biosciences Inc2.4M+0.0%$9094万8.2%
5ALMS Alumis Inc2.8M+0.0%$7966万7.2%
6AVBP Arrivent Biopharma Inc2.0M+0.0%$6847万6.2%
7TSHA Taysha Gene Therapies Inc9.7M+9.4%$6601万5.9%
8BIOA Bioage Labs Inc1.7M+0.0%$4284万3.9%
9MIRM Mirum Pharmaceuticals Inc338,900+0.0%$3968万3.6%
10KYMR Kymera Therapeutics Inc310,000−27.1%$3555万3.2%
11AKTS Aktis Oncology Inc960,847+0.0%$3097万2.8%
12XENE Xenon Pharmaceuticals Inc490,000+0.0%$2958万2.7%
13PALI Palisade Bio Inc10.3M+0.0%$2148万1.9%
14OCUL Ocular Therapeutix Inc2.1M−34.5%$2038万1.8%
15IRON Disc Medicine Inc270,000+0.0%$1975万1.8%
16SMMT Summit Therapeutics Inc1.2M—$1821万1.6%
17PHVS Pharvaris N V456,721+176.8%$1579万1.4%
18ANL Adlai Nortye Ltd934,716—$1075万1.0%
19DTIL Precision Biosciences Inc1.4M−39.6%$1061万1.0%
20DBVT Dbv Technologies S A574,200+0.0%$942万0.8%
21FTH Faeth Therapeutics Inc361,010—$903万0.8%
22GYRE Gyre Therapeutics Inc954,416—$629万0.6%
23TRVI Trevi Therapeutics Inc315,000−78.8%$587万0.5%
24UNCY Unicycive Therapeutics Inc1.0M+0.0%$469万0.4%
25CNTX Context Therapeutics Inc3.0M−41.9%$169万0.2%
26GOSS Gossamer Bio Inc7.8M+0.0%$128万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。